As of 4:00pm ET
| +0.33 / +0.56%|
The 2 analysts offering 12-month price forecasts for Anika Therapeutics Inc have a median target of 58.50, with a high estimate of 60.00 and a low estimate of 57.00. The median estimate represents a -1.45% decrease from the last price of 59.36.
The current consensus among 2 polled investment analysts is to Buy stock in Anika Therapeutics Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.